Information Provided By: 
Fly News Breaks for July 11, 2017
PODD
Jul 11, 2017 | 08:01 EDT
Canaccord analyst Kyle Rose said his survey following last month's ADA conference showed an increasing demand for insulin pumps as well as expectations that Insulet's Dash product will gain market share over the next 18 months. He believes the company is entering a period of product cycle growth, leaving him increasingly bullish. Rose maintained his Hold rating but raised his price target to $50 from $42 on Insulet shares.
News For PODD From the Last 2 Days
There are no results for your query PODD
